These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2469269)

  • 1. [Protective properties of Vi-antigen preparations as dependent on their adhesin content].
    Alliluev AP; Kotel'nikova OV; Korneeva SA; Fish NG; Kulinich LI
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Dec; (12):21-6. PubMed ID: 2469269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polysaccharides and their common proteinic carrier in the Vi antigens of Citrobacter ballerup and Salmonella typhi Ty2.
    Barber C
    Microbios; 1981; 32(128):71-6. PubMed ID: 6176838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of Vi monoclonal antibodies and their application as diagnostic reagents.
    Tsang RS; Chau PY
    J Clin Microbiol; 1987 Mar; 25(3):531-5. PubMed ID: 3571457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of adhesin in the polymeric structure of Vi-antigen].
    Kravtsov EG; Fish NG; Kulinich LI; Alliluev AP; Kotel'nikova OV
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Feb; (2):29-32. PubMed ID: 2728697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vi antigen and microbial adhesion factors. The detection of adhesins in commercial Vi antigen preparations].
    Kravtsov EG; Fish NG; Kulinich LI; Alliluev AP; Kotel'nikova OV
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Nov; (11):33-7. PubMed ID: 2868591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals.
    Szu SC; Stone AL; Robbins JD; Schneerson R; Robbins JB
    J Exp Med; 1987 Nov; 166(5):1510-24. PubMed ID: 3681191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi.
    Robbins JD; Robbins JB
    J Infect Dis; 1984 Sep; 150(3):436-49. PubMed ID: 6207249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies against Vi antigen production and characterization.
    Pieńkowska D; Kunikowska D; Głośnicka R
    Bull Inst Marit Trop Med Gdynia; 1993-1994; 44-45(1-4):89-93. PubMed ID: 7580356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the immunogenicity and biological activity of the Citrobacter freundii Vi-CRM197 conjugate as a vaccine for Salmonella enterica serovar Typhi.
    Rondini S; Micoli F; Lanzilao L; Hale C; Saul AJ; Martin LB
    Clin Vaccine Immunol; 2011 Mar; 18(3):460-8. PubMed ID: 21248155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection in a mouse peritonitis model mediated by iron-regulated outer-membrane protein of Salmonella typhi coupled to its Vi antigen.
    Chibber S; Bhardwaj SB
    J Med Microbiol; 2004 Jul; 53(Pt 7):705-709. PubMed ID: 15184544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunochemical properties of Vi antigen from Salmonella typhi Ty2: presence of two antigenic determinants.
    Szewczyk B; Taylor A
    Infect Immun; 1980 Aug; 29(2):539-44. PubMed ID: 6163712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the Salmonella paratyphi C Vi polysaccharide.
    Daniels EM; Schneerson R; Egan WM; Szu SC; Robbins JB
    Infect Immun; 1989 Oct; 57(10):3159-64. PubMed ID: 2506132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of an (O,H,Vi)-free immunoprotective antigenic fraction with mannose receptor-like activity from Salmonella typhi.
    Jouin H; Staub AM; Alouf JE
    J Infect Dis; 1981 Jan; 143(1):106-13. PubMed ID: 7217708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vi Capsular Polysaccharide Produced by Recombinant
    Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
    Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic regulation of variable Vi antigen expression in a strain of Citrobacter freundii.
    Snellings NJ; Johnson EM; Kopecko DJ; Collins HH; Baron LS
    J Bacteriol; 1981 Feb; 145(2):1010-7. PubMed ID: 6161917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity of Vi-related antigens in the microcapsule of Salmonella typhi.
    Szewczyk B; Taylor A
    Infect Immun; 1980 Dec; 30(3):661-7. PubMed ID: 6164644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An adhesion protein of Salmonella enterica serovar Typhi is required for pathogenesis and potential target for vaccine development.
    Ghosh S; Chakraborty K; Nagaraja T; Basak S; Koley H; Dutta S; Mitra U; Das S
    Proc Natl Acad Sci U S A; 2011 Feb; 108(8):3348-53. PubMed ID: 21300870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ineffectiveness of Vi and chemically treated endotoxins as typhoid vaccines in mice challenged with a Salmonella typhosa-Salmonella typhimurium hybrid.
    Diena BB; Ryan A; Wallace R; Ashton FE; Johnson EM; Baron LS
    Infect Immun; 1975 Dec; 12(6):1470-1. PubMed ID: 1107227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic analysis of Barber's protein antigen prepared from Salmonella typhi and demonstration of protein-specific antibodies in sera of typhoid patients.
    Tsang RS; Lui SW; Chau PY
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Apr; 254(2):244-52. PubMed ID: 6426195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A chemical typhoid vaccine containing a surface-antigen complex including the K-antigen].
    Stepanova LK; Belaia IuA; Sergeeva NS; Ageeva VA; Petrukhin VG
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (1):51-6. PubMed ID: 7520650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.